Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1968 3
1969 2
1970 6
1972 2
1973 5
1974 7
1975 10
1976 9
1977 10
1978 12
1979 9
1980 11
1981 13
1982 8
1983 15
1984 14
1985 8
1986 16
1987 8
1988 10
1989 4
1990 4
1991 1
1992 4
1993 6
1994 2
1995 5
1996 3
1997 4
1998 6
1999 4
2000 3
2001 13
2002 12
2003 8
2004 2
2005 3
2006 8
2007 8
2008 6
2009 3
2010 7
2011 7
2012 5
2013 7
2014 5
2015 4
2016 6
2017 3
2018 9
2019 7
2020 11
2021 9
2022 8
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

364 results
Results by year
Filters applied: . Clear all
Page 1
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T. Rae-Grant A, et al. Among authors: lisak r. Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347. Neurology. 2018. PMID: 29686116
COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.
Sriwastava S, Tandon M, Podury S, Prasad A, Wen S, Guthrie G, Kakara M, Jaiswal S, Subedi R, Elkhooly M, Lisak RP. Sriwastava S, et al. Among authors: lisak rp. J Neurol. 2021 Dec;268(12):4448-4478. doi: 10.1007/s00415-021-10611-9. Epub 2021 May 19. J Neurol. 2021. PMID: 34009454 Free PMC article. Review.
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study.
Rivner MH, Quarles BM, Pan JX, Yu Z, Howard JF Jr, Corse A, Dimachkie MM, Jackson C, Vu T, Small G, Lisak RP, Belsh J, Lee I, Nowak RJ, Baute V, Scelsa S, Fernandes JA, Simmons Z, Swenson A, Barohn R, Sanka RB, Gooch C, Ubogu E, Caress J, Pasnoor M, Xu H, Mei L. Rivner MH, et al. Among authors: lisak rp. Muscle Nerve. 2020 Sep;62(3):333-343. doi: 10.1002/mus.26985. Epub 2020 Jun 10. Muscle Nerve. 2020. PMID: 32483837 Free PMC article.
Farewell editorial.
Lisak RP. Lisak RP. J Neurol Sci. 2013 Jul 15;330(1-2):1. doi: 10.1016/j.jns.2013.05.007. Epub 2013 May 17. J Neurol Sci. 2013. PMID: 23684669 No abstract available.
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
Howard JF Jr, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ; Zilucoplan MG Study Group; Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF Jr, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. Howard JF Jr, et al. Among authors: lisak rp. JAMA Neurol. 2020 May 1;77(5):582-592. doi: 10.1001/jamaneurol.2019.5125. JAMA Neurol. 2020. PMID: 32065623 Free PMC article. Clinical Trial.
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T. Rae-Grant A, et al. Among authors: lisak r. Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345. Neurology. 2018. PMID: 29686117 Review.
Multiple sclerosis.
Moore MJ, Behan PO, Lisak RP. Moore MJ, et al. Among authors: lisak rp. Postgrad Med. 1973 Apr;53(4):75-80. doi: 10.1080/00325481.1973.11713419. Postgrad Med. 1973. PMID: 4576715 Review. No abstract available.
Acquired demyelinating polyneuropathies.
Lisak RP, Brown MJ. Lisak RP, et al. Semin Neurol. 1987 Mar;7(1):40-8. doi: 10.1055/s-2008-1041404. Semin Neurol. 1987. PMID: 3332446 Review. No abstract available.
Myasthenia gravis.
Aarli JA, Gilhus NE, Lisak RP, Mantegazza R, Suzuki S. Aarli JA, et al. Among authors: lisak rp. Autoimmune Dis. 2011;2011:697575. doi: 10.4061/2011/697575. Epub 2012 Jan 24. Autoimmune Dis. 2011. PMID: 22312479 Free PMC article. No abstract available.
364 results